Discover 1,474 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Amgen
Location:
Code:
NCT06660173
Conditions
Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Maridebart Cafraglutide
Placebo
Sponsor:
University of Washington
Location:
Code:
NCT04175431
Conditions
Prostate Adenocarcinoma
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Positron Emission Tomography
Lymphadenectomy
Radiation Therapy
Abiraterone Acetate
Prednisone
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05172973
Conditions
Aortic Valve Insufficiency
Aortic Valve Stenosis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
SAPIEN X4 THV
Sponsor:
Fred Hutchinson Cancer Center
Location:
Code:
NCT03399773
Conditions
Acute Biphenotypic Leukemia
Acute Lymphoblastic Leukemia
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Hematopoietic and Lymphoid Cell Neoplasm
Myelodysplastic Syndrome
Eligibility Criteria
Sex: All
Age: 10 - 65
Healthy Volunteers: Not accepted
Interventions
Dilanubicel
Cyclophosphamide
Fludarabine
Thiotepa
Total-Body Irradiation
Sponsor:
University of Washington
Location:
Code:
NCT05566431
Conditions
Severe Traumatic Brain Injury
Eligibility Criteria
Sex: All
Age: 1 - 12
Healthy Volunteers: Not accepted
Interventions
ICP
CREVICE
Sponsor:
Seattle Institute for Biomedical and Clinical Research
Location:
Code:
NCT04049331
Conditions
Hypogonadism, Male
Fatigue Syndrome, Chronic
Eligibility Criteria
Sex: Male
Age: 18 - 54
Healthy Volunteers: Not accepted
Interventions
Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
placebo
Sponsor:
Sawa Ito, MD
Location:
Code:
NCT06529731
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Interferon gamma-1b
Donor Leukocyte Infusion (DLI)
Sponsor:
Fred Hutchinson Cancer Center
Location:
Code:
NCT04375631
Conditions
Recurrent Acute Myeloid Leukemia
Recurrent Chronic Myelomonocytic Leukemia
Recurrent Myelodysplastic Syndrome
Refractory Acute Myeloid Leukemia
Refractory Chronic Myelomonocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cladribine
Cyclophosphamide
Cyclosporine
Cytarabine
Filgrastim
Sponsor:
University of Washington
Location:
Code:
NCT04305782
Conditions
Lower Limb Amputation Below Knee (Injury)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Release/Relock Socket - In Lab
Release/Relock Socket - Out of Lab
Release/Relock Socket & Control
As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.
Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.
For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.
By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.
Seattle's reputation as a hub for clinical research is supported by its world-class research institutions and a collaborative healthcare community studying a wide range of medical conditions.
Seattle is a leader in cancer research, with institutions such as the Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance at the forefront. As the leading cause of death in the wider state of Washington, research here focuses on cutting-edge areas such as immunotherapy and personalized medicine.
Trials explore innovative treatments like CAR-T cell therapy, which modifies a patient’s own immune cells to target cancer, and novel drug combinations designed to overcome resistance to existing therapies. These efforts aim to improve survival rates and quality of life for cancer patients.
Seattle’s expertise in neurological research is reflected by institutions like the University of Washington’s Alzheimer’s Disease Research Center and the Allen Institute for Brain Science.
Clinical trials in this area delve into understanding the molecular and genetic underpinnings of neurodegenerative diseases. For instance, research on Alzheimer’s disease includes trials investigating potential disease-modifying drugs and advanced imaging techniques to detect early signs of cognitive decline. Similarly, studies on Parkinson’s disease and multiple sclerosis (MS) focus on new therapies that could slow disease progression or improve symptoms.
The city’s global health focus is evident in its research on infectious diseases. Institutions like the Fred Hutchinson Cancer Research Center and the University of Washington conduct trials on diseases such as HIV/AIDS, tuberculosis, and emerging pathogens like COVID-19.
Research here includes developing new vaccines, testing antiviral therapies, and exploring novel strategies for disease prevention and management. Seattle’s role in infectious disease research is bolstered by its commitment to global health and its response to emerging health threats.
Seattle’s research into autoimmune diseases such as rheumatoid arthritis, prurigo nodularis and lupus is conducted at leading institutions like the Fred Hutchinson Cancer Research Center and the University of Washington. Clinical trials explore new treatments aimed at modulating the immune system to reduce inflammation and damage associated with autoimmune conditions.
Clinical trials in Seattle also address metabolic disorders, including diabetes and obesity. The city’s research focuses on innovative approaches such as new medications, metabolic monitoring technologies, and lifestyle interventions designed to improve metabolic health. Studies investigate ways to better manage blood sugar levels, reduce obesity-related complications, and understand the metabolic pathways involved in these conditions.
Seattle’s research institutions, including the Swedish Medical Center and the University of Washington, are heavily involved in trials related to cardiovascular health. With heart disease being a leading cause of death in the state, these studies often focus on heart failure, coronary artery disease, and hypertension.
Current research includes evaluating the efficacy of new medications designed to manage heart failure, innovative interventional procedures such as catheter-based treatments, and lifestyle interventions aimed at preventing cardiovascular disease. Seattle’s emphasis on heart health is supported by its strong network of cardiologists and researchers dedicated to improving patient outcomes.
In Seattle, clinical trials are rigorously regulated by a combination of federal, state, and local guidelines, ensuring ethical and scientific integrity. Federal oversight is provided by the FDA, which enforces Good Clinical Practice (GCP) standards, and the Office for Human Research Protections (OHRP), which mandates Institutional Review Board (IRB) review and participant protection.
At the state level, the Washington State Department of Health oversees compliance with health regulations, while local IRBs provide additional scrutiny and oversight. Local research institutions and networks further uphold these standards, providing a well-regulated environment that supports innovative and responsible clinical research.
Participating in a clinical trial offers a unique chance to access cutting-edge treatments and therapies in the early stages of development and before they are widely available. Participants also benefit from exceptional care provided by top healthcare professionals, who ensure personalized attention and rigorous monitoring throughout the study.
Being involved in clinical trials is crucial for advancing medical research, often leading to significant progress in treatment and prevention for various conditions. By taking part, individuals not only access groundbreaking medical options early but also play a vital role in expanding scientific knowledge, ultimately improving healthcare outcomes for future patients.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: